About Lakepharma, inc.
LakePharma, Inc. is a biologics service provider that specializes in antibody and protein engineering, cell line development, protein production, and analysis. The company has been providing high-quality services to the biotech and pharmaceutical industries for over 10 years.
One of the key strengths of LakePharma is its expertise in antibody engineering. The company offers a range of services related to antibody discovery, optimization, and humanization. Its team of experienced scientists uses cutting-edge technologies such as phage display and hybridoma technology to generate high-affinity antibodies against a variety of targets.
In addition to antibody engineering, LakePharma also provides services related to protein engineering. Its team can modify proteins for improved stability, solubility, or activity using techniques such as site-directed mutagenesis or fusion protein design.
Another area where LakePharma excels is cell line development. The company has developed proprietary platforms for generating stable cell lines expressing recombinant proteins at high levels. These platforms can be used for both transient expression (for rapid screening) and stable expression (for long-term production).
Once a protein or antibody has been engineered or expressed in a cell line, it needs to be purified and analyzed. This is another area where LakePharma's expertise comes into play. The company offers a range of purification methods (such as affinity chromatography or ion exchange chromatography) tailored to each specific project's needs.
Finally, LakePharma provides analytical services that help clients characterize their proteins or antibodies fully. These include assays such as ELISA (enzyme-linked immunosorbent assay), Western blotting (protein detection), HPLC (high-performance liquid chromatography), mass spectrometry (protein identification), among others.
Overall, LakePharma's comprehensive suite of biologics services makes it an ideal partner for companies looking to develop novel therapeutics based on antibodies or other recombinant proteins."
lakepharma.com
